R&D pipeline: balanced with focus
Research and development programmes continue to progress year by year with a strong focus in four key areas: respiratory, neonatology, rare disease and special care.
Diseases covered: Obstructive Pulmonary diseases (Asthma, COPD, Bronchiectasis); Non-Obstructive pulmonary diseases (Interstitial Lung Diseases – ILD, Idiopathic Pulmonary Fibrosis - IPF); Pulmonary Vascular Diseases (Pulmonary Arterial Hypertension – PAH; and Pulmonary Hypertension due to Interstitial Lung Disease - PH-ILD)
Encompasses products and services that enable the treatment of respiratory
Diseases covered: Inborn errors of metabolism, rare hematologic and immunologic diseases, ophthalmology disorders
Focuses on the treatment of patients living with rare or ultra-rare diseases.
Diseases covered (Special Care & Neonatology): Neonatal conditions of the lung, gut and brain in both preterm and term infants, acute cardiac and hypertensive disorders, solid organ transplant. Includes also micronutrition based on amino-science for personal wellbeing.
Provides a blend of products and services designed to support specialized care delivered by medical professionals in acute hospital settings, along with food supplements for consumer self-care.
|
Indication / Disease |
Trade Name |
Active Principle |
Code |
Formulation |
Region |
Phase ❋ 1 2 3 4 |
Alliance / Partnership |
|---|
Explore our Pipeline
Action Areas